These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 8968240)

  • 1. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE; Thong KJ; Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
    Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Thong KJ; Lynch P; Baird DT
    Contraception; 1996 Aug; 54(2):97-100. PubMed ID: 8842586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R; Naji S; Russell I; Templeton A
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
    Urquhart DR; Templeton AA
    Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C; Olund A
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
    Jensen JT; Astley SJ; Morgan E; Nichols MD
    Contraception; 1999 Mar; 59(3):153-9. PubMed ID: 10382077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M; Van Look PF
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's evaluation of three early abortion methods.
    Holmgren K
    Acta Obstet Gynecol Scand; 1992 Dec; 71(8):616-23. PubMed ID: 1336921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical abortion in Britain.
    Baird DT
    Br J Obstet Gynaecol; 1994 May; 101(5):367-8. PubMed ID: 8018604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin.
    Phillips K; Berry C; Mathers AM
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):175-6. PubMed ID: 8730620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.